title: [Tolerability of a new non-ionic contrast medium, iopromide in x-ray computed tomography. Comparison with ioxaglate 320 mgI/ml].
abstract: Three randomized prospective and comparative trials were conducted in 165 patients undergoing brain (80) and whole body (85) CT scans. The two products compared where a new non-ionic contrast medium iopromide 300 (brain) and 370 (whole body) and the ionic low osmolar contrast medium, ioxaglate 320. Imaging quality was not different but the tolerance of the non-ionic medium was significantly better (p less than 0.05).
authors.forename: D
authors.initials: D
authors.lastname: Fredy
authors.forename: F
authors.initials: F
authors.lastname: Heitz
authors.forename: D
authors.initials: D
authors.lastname: Mathieu
authors.forename: N
authors.initials: N
authors.lastname: Vasile
mesh_terms: D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D007485:Ioxaglic Acid
vernacular_title: Etude de la tolérance d'un nouveau produit de contraste non ionique, l'iopromide en scanographie. Comparison avec l'ioxaglate 320 mgI/ml.